Thomson Reuters Foundation: ‘A shot can end the stigma’: African women pin hopes on anti-HIV jab
“…A new injectable HIV prevention drug, called cabotegravir, that is taken every two months has proved nine times more effective in preventing HIV than the commonly used Truvada PrEP daily tablets, a study found last month. HIV/AIDS experts have described the results as ground-breaking, especially for Africa — where new infections disproportionately affect women — and more options to prevent HIV are urgently needed. Not only will the new drug give women and girls across the region a more acceptable option, new transmissions will fall sharply, they said…” (Bhalla, 12/1).

TIME: On World AIDS Day, Those Who Fought the 1980s Epidemic Find Striking Differences and Tragic Parallels in COVID-19
“More than three decades after the World Health Organization (WHO) launched the first World AIDS Day on Dec. 1, 1988, the world’s leading global health organization faces another public health crisis in COVID-19. On this World AIDS Day, those who raised awareness of HIV, the virus that causes AIDS, find devastating similarities and haunting differences in America’s response to both crises…” (Waxman, 12/1).

VOA News: Affordable Treatment Available Soon for Children Living With HIV in Poor Countries
“Affordable treatment will soon be available for children living with HIV in low- and middle-income countries thanks to an agreement between the global health agency UNITAID and the Clinton Health Access Initiative, or CHAI. … UNITAID and CHAI plan to roll out the first antiretroviral treatments specifically designed for children next year in six African countries — Benin, Kenya, Malawi, Nigeria, Uganda, and Zimbabwe…” (Schlein, 12/1).

VOA News: World ‘Way Off’ Targets of Getting Control of HIV Transmission
“Four years ago, governments around the world committed to achieving targets in testing and treating the vast majority of people with HIV to the point where the AIDS pandemic would end. … Under Dr. Demetre Daskalakis’ direction, the goal by the United Nations in 2016 was achieved in New York City, but Dr. Chris Beyrer, an AIDS researcher at Johns Hopkins University, says it is way off track elsewhere. Beyrer spoke to VOA recently…” (Pearson, 12/1).